Considering the emerging role of basophils in atopic itching flare-ups associated with allergen exposure [18], it would be desirable for anti-IgE therapy to be specifically assessed in clinical trials as a therapeutic agent for AD-associated itching. Here, IGHE is linked to Alzheimer disease.